Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials.
Gian Luca Di TannaJoshua K PorterRichard B LiptonAnthony J HatswellSandhya SapraGuillermo VillaPublished in: Health and quality of life outcomes (2019)
ClinicalTrials.gov numbers of the trials used in this study: STRIVE, NCT02456740 (registered May 14, 2015), ARISE, NCT02483585 (registered June 12, 2015) and NCT02066415 (registered Feb 17, 2014).